Unimed Penguin Acquires Minsheng Pharmaceutical Network in Strategic Move to Enter B2B Healthcare Market

Due to the unique nature of pharmaceutical products, the e-commerce sector for medicines has always been subject to strict national regulation., which makesClass A licenses are extremely scarce in the industry.. OneAlways，Certificate A isA significant barrier for third-party pharmaceutical e-commerce platforms. This acquisition suggests that Unnamed Penguin is highly likely to in the futureB2B Pharmaceutical Transactions Enter the Greater Health Market.

Unnamed Penguin was established inNovember 2015,YesOneInternet+Big Health SectorofB2B startup dedicated to shortening the pharmaceutical supply chain and building infrastructure for the pharmaceutical commerce sector.In February 2016, Unnamed Penguin officially commenced operations.

Unnamed PenguinFor3 trillionofThe Big Health Market,Aimed atServing China450,000 pharmacies, over 900,000 clinics and hospitals, more than 10,000 pharmaceutical commercial companies, and over 5,000 pharmaceutical manufacturers, comeHelp pharmaceutical manufacturers and commercial companies expand online sales channels, reduce transaction costs, and improve transaction efficiency,Meanwhile, Unnamed Penguin alsoOffering pharmacies and clinics a wider range ofPharmaceuticalsProduct varieties, specifications, and lower purchase prices.

In March 2016, Unnamed Penguin secured tens of millions of RMB in angel financing, led by Matrix Partners China. The company commenced operations., namely securing financing, which brought significant attention to Unnamed Penguin. The company’s competitive advantage lies in its team’s internet DNA and capabilities.

Unnamed PenguinofInternet+Pharmaceutical Founding Teamin China,Among themwith a background in the internet industry7BitMemberAllFrom Tencent, Alibaba, and the InternetProfessional PracticeExperience exceeding1964. Meanwhile, team members with expertise in the pharmaceutical industry possess decades of experience within the sector.

Mr. Zou Xiaoliang, founder of Unnamed Penguin, onceServed at Alibaba and Tencent successively between 2004 and 2014, possessing10 years of internet industry experience. During his tenure at Alibaba, Mr. Zou XiaoliangServing as the Director of Alibaba’s Business Intelligence Department, he is also one of the core founders of Alibaba Group’s Business Intelligence team. During his tenure at Tencent, he served as Vice General Manager and was the primary executive responsible for business operations and online media products.Over a seven-year period, he helped scale Tencent’s advertising business from annual revenues of less than RMB 300 million to over RMB 10 billion, establishing himself as an expert in strategy formulation, business intelligence, operations, and media products. Mr. Zou Xiaoliang serves as an Expert Committee Member of the Internet Society of China, an International Expert Committee Member of I-COM, a Marketing Advisor to Caixin Media, and an Expert at Caixin Think Tank. He is also a Distinguished Entrepreneurship Mentor at Peking University’s Incubator and Vice President of the Pharmaceutical Logistics Branch of the China Federation of Logistics & Purchasing. Mr. Zou Xiaoliang is currently a Ph.D. candidate in Management at the National School of Development at Peking University and Fordham University in the United States.

In June 2016, Unnamed Penguin established a deep strategic partnership with Jointown Pharmaceutical Group.JointownofAllOTC Category to Be Launched Under Unnamed PenguinofPharmaceutical e-commerce platform, and in warehousingandLogistics: Opening Up Its Third-Party Logistics Services,Committed toUnder Unnamed PenguinofProvide services to customers of pharmaceutical e-commerce platforms.It is reported that the cooperationBoth parties will commit to exploring ways to enhance the supply chain industryofDistribution Efficiency.

Minsheng Pharmaceutical E-Commerce Network (abbreviated as MinshengPharmaceuticals) is a third-party internet drug trading platform approved by the State Food and Drug AdministrationTransactionService Platform,The platform aims toForMedical Institution、PharmaceuticalsProductionEnterprise, DrugOperationEnterprises, pharmaceutical retail enterprises, etc., provide services such as internet-based supply and demand information publishing, online transactions, online settlements, and third-party pharmaceutical logistics distribution network support for pharmaceuticals, medical devices, health supplements, medical consumables, raw materials, and other products.。

Unnamed Penguin did not disclose the specific amount of this transaction, but judging from market conditions, several recent casesDomesticAcquisitions involving companies with Class A qualifications have transaction amounts approaching RMB 100 million. As a startup, how Unnamed Penguin managed to complete such a significant acquisition has sparked considerable speculation regarding the specific terms of the deal. Sources close to Minsheng Pharmaceutical stated that, in addition to corporate funding, the founder also made personal investments. Meanwhile, Fangda Partners, a top-tier domestic law firm, served as legal counsel for the transaction.. Currently, Minsheng PharmaceuticalWebsiteMajor overhaul completed; header displays“Test”

Currently, the Minsheng Pharmaceutical website (yiyao.cc) has undergone a major revamp, with the header displaying the word “Test.” Staff from VCBeat (WeChat ID: vcbeat) tested the site and found it to offer a comprehensive product range, user-friendly navigation, and a pleasant user experience, reflecting the product and technical expertise of seasoned internet veterans.

In recent years,In obtainingAmid the rising cost of consumer-facing traffic, B2BMode,“Internet+”with the industryofDeep integration is a more promising direction for entrepreneurship.Recently,Ma Huateng, Chairman of the Board and Chief Executive Officer of Tencent, atAt the “2016 China Internet Plus” Summit, it was stated that “all industries should more clearly recognize that the internet is not a new economy unrelated to themselves.”、New Frontier: The Internet is inextricably linked to every industry; failing to embrace it will result in obsolescence.“

The circulation of pharmaceuticals and related general health products has always been a massive market worth trillions. Due to high industry barriers, in the rapidly evolving internetAmid the B2B startup boom, it has appeared slow to gain momentum. Over the past two years, favorable industry policies have been continuously introduced, and measures such as the “Two-Invoice System” have further standardized the pharmaceutical distribution market, creating greater opportunities for online pharmaceutical platforms. The Unnamed Penguin team brings extensive experience from top-tier internet companies, along with members who possess substantial backgrounds in the pharmaceutical industry. The entry of such a startup is expected to drive more positive changes in the online pharmaceutical sector.